智通财经APP讯,*ST科华(002022.SZ)发布公告,近日,公司收到国家药品监督管理局颁发“人类免疫缺陷病毒抗原抗体(HIVAg/Ab)检测试剂盒(化学发光法)”的《医疗器械注册证》(体外诊断试剂)。
据悉,该产品用于体外定性检测人血清或血浆中的人类免疫缺陷病毒(HIV1/2)抗体和HIV-1p24抗原。
智通财经APP讯,*ST科华(002022.SZ)发布公告,近日,公司收到国家药品监督管理局颁发“人类免疫缺陷病毒抗原抗体(HIVAg/Ab)检测试剂盒(化学发光法)”的《医疗器械注册证》(体外诊断试剂)。
据悉,该产品用于体外定性检测人血清或血浆中的人类免疫缺陷病毒(HIV1/2)抗体和HIV-1p24抗原。
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.